{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:38:45Z","timestamp":1784194725178,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T00:00:00Z","timestamp":1606867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T00:00:00Z","timestamp":1606867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Longitudinal characterization of SARS-CoV-2 PCR testing from COVID-19 patient\u2019s nasopharynx and its juxtaposition with blood-based IgG-seroconversion diagnostic assays is critical to understanding SARS-CoV-2 infection durations. Here, we retrospectively analyze 851 SARS-CoV-2-positive patients with at least two positive PCR tests and find that 99 of these patients remain SARS-CoV-2-positive after 4 weeks from their initial diagnosis date. For the 851-patient cohort, the mean lower bound of viral RNA shedding was 17.3 days (SD: 7.8), and the mean upper bound of viral RNA shedding from 668 patients transitioning to confirmed PCR-negative status was 22.7 days (SD: 11.8). Among 104 patients with an IgG test result, 90 patients were seropositive to date, with mean upper bound of time to seropositivity from initial diagnosis being 37.8 days (95% CI: 34.3\u201341.3). Our findings from juxtaposing IgG and PCR tests thus reveal that some SARS-CoV-2-positive patients are non-hospitalized and seropositive, yet actively shed viral RNA (14 of 90 patients). This study emphasizes the need for monitoring viral loads and neutralizing antibody titers in long-term non-hospitalized shedders as a means of characterizing the SARS-CoV-2 infection lifecycle.<\/jats:p>","DOI":"10.1038\/s41420-020-00375-y","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T08:05:39Z","timestamp":1606896339000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Long-term SARS-CoV-2 RNA shedding and its temporal association to IgG seropositivity"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6235-5577","authenticated-orcid":false,"given":"Vineet","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. J.","family":"Venkatakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Puranik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Kirkup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agustin","family":"Lopez-Marquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas W.","family":"Challener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elitza S.","family":"Theel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"O\u2019Horo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Binnicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter K.","family":"Kremers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"William A.","family":"Faubion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7796-7680","authenticated-orcid":false,"given":"Andrew D.","family":"Badley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy W.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Gores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Halamka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"William G.","family":"Morice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7434-9211","authenticated-orcid":false,"given":"Venky","family":"Soundararajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,2]]},"reference":[{"key":"375_CR1","unstructured":"Johns Hopkins Coronavirus Resource Center. https:\/\/coronavirus.jhu.edu\/ (2020)."},{"key":"375_CR2","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/S0140-6736(20)31034-5","volume":"395","author":"AL Phelan","year":"2020","unstructured":"Phelan, A. L. COVID-19 immunity passports and vaccination certificates: scientific, equitable, and legal challenges. Lancet 395, 1595\u20131598 (2020).","journal-title":"Lancet"},{"key":"375_CR3","doi-asserted-by":"publisher","unstructured":"Chen, Y. et al. The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients. J. Med. Virol. https:\/\/doi.org\/10.1002\/jmv.25825 (2020).","DOI":"10.1002\/jmv.25825"},{"key":"375_CR4","doi-asserted-by":"publisher","first-page":"101619","DOI":"10.1016\/j.tmaid.2020.101619","volume":"34","author":"Y-M Qu","year":"2020","unstructured":"Qu, Y.-M., Kang, E.-M. & Cong, H.-Y. Positive result of Sars-Cov-2 in sputum from a cured patient with COVID-19. Travel Med. Infect. Dis. 34, 101619 (2020).","journal-title":"Travel Med. Infect. Dis."},{"key":"375_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/emi.2012.28","volume":"1","author":"T Suo","year":"2020","unstructured":"Suo, T. et al. ddPCR: a more accurate tool for SARS-CoV-2 detection in low viral load specimens. Emerg. Microbes Infect. 1, 1\u201330 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"375_CR6","doi-asserted-by":"publisher","unstructured":"Dong, L. et al. Highly accurate and sensitive diagnostic detection of SARS-CoV-2 by digital PCR. Talanta. https:\/\/doi.org\/10.1101\/2020.03.14.20036129 (2020).","DOI":"10.1101\/2020.03.14.20036129"},{"key":"375_CR7","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s10096-020-03913-9","volume":"39","author":"B La Scola","year":"2020","unstructured":"La Scola, B. et al. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. Eur. J. Clin. Microbiol. Infect. Dis. 39, 1059\u20131061 (2020).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"375_CR8","unstructured":"CDC. Coronavirus Disease 2019 (COVID-19). Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/if-you-are-sick\/end-home-isolation.html (2020)."},{"key":"375_CR9","doi-asserted-by":"publisher","unstructured":"Richardson, S. et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. https:\/\/doi.org\/10.1001\/jama.2020.6775 (2020).","DOI":"10.1001\/jama.2020.6775"},{"key":"375_CR10","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395, 1054\u20131062 (2020).","journal-title":"Lancet"},{"key":"375_CR11","doi-asserted-by":"publisher","unstructured":"Kucirka, L. M., Lauer, S. A., Laeyendecker, O., Boon, D. & Lessler, J. Variation in false-negative rate of reverse transcriptase polymerase chain reaction\u2013based SARS-CoV-2 tests by time since exposure. Ann. Int. Med. https:\/\/doi.org\/10.7326\/m20-1495 (2020).","DOI":"10.7326\/m20-1495"},{"key":"375_CR12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","volume":"581","author":"R W\u00f6lfel","year":"2020","unstructured":"W\u00f6lfel, R. et al. Virological assessment of hospitalized patients with COVID-2019. Nature 581, 465\u2013469 (2020).","journal-title":"Nature"},{"key":"375_CR13","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41591-020-0869-5","volume":"26","author":"X He","year":"2020","unstructured":"He, X. et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat. Med. 26, 672\u2013675 (2020).","journal-title":"Nat. Med."},{"key":"375_CR14","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S2468-1253(20)30083-2","volume":"5","author":"Y Wu","year":"2020","unstructured":"Wu, Y. et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol. Hepatol. 5, 434\u2013435 (2020).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"375_CR15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S1473-3099(20)30196-1","volume":"20","author":"KK-W To","year":"2020","unstructured":"To, K. K.-W. et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect. Dis. 20, 565\u2013574 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"375_CR16","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.7150\/ijbs.45123","volume":"16","author":"G Zhou","year":"2020","unstructured":"Zhou, G. & Zhao, Q. Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2. Int. J. Biol. Sci. 16, 1718\u20131723 (2020).","journal-title":"Int. J. Biol. Sci."},{"key":"375_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001213","volume":"6","author":"S Natesampillai","year":"2010","unstructured":"Natesampillai, S. et al. Patients with discordant responses to antiretroviral therapy have impaired killing of HIV-infected T cells. PLoS Pathog. 6, e1001213 (2010).","journal-title":"PLoS Pathog."},{"key":"375_CR18","doi-asserted-by":"publisher","unstructured":"Korber, B. et al. Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2. https:\/\/doi.org\/10.1101\/2020.04.29.069054 (2020).","DOI":"10.1101\/2020.04.29.069054"},{"key":"375_CR19","doi-asserted-by":"publisher","first-page":"e33354","DOI":"10.7554\/eLife.33354","volume":"7","author":"J Klinkhammer","year":"2018","unstructured":"Klinkhammer, J. et al. IFN-\u03bb prevents influenza virus spread from the upper airways to the lungs and limits virus transmission. Elife 7, e33354 (2018).","journal-title":"Elife"},{"key":"375_CR20","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/nm.3350","volume":"19","author":"S Sridhar","year":"2013","unstructured":"Sridhar, S. et al. Cellular immune correlates of protection against symptomatic pandemic influenza. Nat. Med. 19, 1305\u20131312 (2013).","journal-title":"Nat. Med."},{"key":"375_CR21","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/s41564-020-0761-6","volume":"5","author":"CBF Vogels","year":"2020","unstructured":"Vogels, C. B. F. et al. Analytical sensitivity and efficiency comparisons of SARS-COV-2 qRT-PCR primer-probe sets. Nat. Microbiol. 5, 1299\u20131305 (2020).","journal-title":"Nat. Microbiol."},{"key":"375_CR22","doi-asserted-by":"publisher","unstructured":"Pawlowski, C. et al. Longitudinal laboratory testing tied to PCR diagnostics in COVID-19 patients reveals temporal evolution of distinctive coagulopathy signatures. https:\/\/doi.org\/10.1101\/2020.05.21.20109439 (2020).","DOI":"10.1101\/2020.05.21.20109439"},{"key":"375_CR23","doi-asserted-by":"publisher","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","volume":"7","author":"M Levi","year":"2020","unstructured":"Levi, M., Thachil, J., Iba, T. & Levy, J. H. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 7, e438\u2013e440 (2020).","journal-title":"Lancet Haematol."},{"key":"375_CR24","first-page":"1","volume":"58","author":"KG Rodino","year":"2020","unstructured":"Rodino, K. G. et al. Evaluation of saline, phosphate-buffered saline, and minimum essential medium as potential alternatives to viral transport media for SARS-CoV-2 testing. J. Clin. Microbiol. 58, 1\u20132 (2020).","journal-title":"J. Clin. Microbiol."},{"key":"375_CR25","unstructured":"Roche diagnostics. cobas\u00ae SARS-CoV-2 Test (for the COVID-19 Coronavirus) | Roche Diagnostics. Diagnostics. https:\/\/diagnostics.roche.com\/us\/en\/products\/params\/cobas-sars-cov-2-test.html (2020)."},{"key":"375_CR26","unstructured":"Abbott RealTime SARS-CoV-2 Assay (EUA) | Abbott Molecular. https:\/\/www.molecular.abbott\/us\/en\/products\/infectious-disease\/RealTime-SARS-CoV-2-Assay (2020)."},{"key":"375_CR27","unstructured":"LOINC. SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay Active. https:\/\/loinc.org\/94563-4\/ (2020)."},{"key":"375_CR28","doi-asserted-by":"crossref","unstructured":"Theel, E. S. et al. The role of antibody testing for SARS-CoV-2: is there one? J. Clin. Microbiol. 58 (2020).","DOI":"10.1128\/JCM.00797-20"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-020-00375-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-020-00375-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-020-00375-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T11:13:42Z","timestamp":1670238822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-020-00375-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,2]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["375"],"URL":"https:\/\/doi.org\/10.1038\/s41420-020-00375-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.02.20120774","asserted-by":"object"}]},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,2]]},"assertion":[{"value":"4 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.D.B. is a consultant for Abbvie, is on scientific advisory boards for nference and Zentalis, and is founder and President of Splissen therapeutics. E.S.T. is on the consulting\/advisory board of Roche Diagnostics\/Accelerate Diagnostics; has speaking associated engagement with Bio-Rad Diagnostics and research associated engagement with Ortho-Clinical Diagnostics. One or more of the investigators associated with this project and Mayo Clinic have a Financial Conflict of Interest in technology used in the research and that the investigator(s) and Mayo Clinic may stand to gain financially from the successful outcome of the research. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic Conflict of Interest policies. The authors from nference have financial interests in nference.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"138"}}